Hepatic Melioidosis: A State-of-the-Art Review

Nitin Gupta1, Chiranjay Mukhopadhyay2, Sundeep Malla3

  • 1Department of Infectious Diseases, Kasturba Medical College, Manipal Academy of Higher Education, Manipal 576104, India.

Insights

Hepatic melioidosis, a liver abscess caused by Burkholderia pseudomallei, often mimics other conditions in immunocompromised individuals. Early recognition of its unique clinical and imaging signs is crucial for effective treatment and improved patient outcomes.

Area of Science:

  • Infectious Diseases
  • Hepatology
  • Microbiology

Background:

  • Hepatic melioidosis is a serious Burkholderia pseudomallei infection affecting the liver, common in South and Southeast Asia.
  • It disproportionately impacts diabetic and immunocompromised individuals, presenting as a subacute or chronic liver abscess.
  • The condition often mimics other liver abscesses due to complex bacterial and host immune interactions.

Purpose of the Study:

  • To highlight the clinical, radiological, and microbiological characteristics of hepatic melioidosis.
  • To emphasize the importance of distinguishing it from other liver abscesses for timely diagnosis.
  • To outline current management strategies and areas for improvement.

Main Methods:

  • Review of clinical presentations and diagnostic challenges of hepatic melioidosis.
  • Analysis of characteristic imaging findings like the honeycomb and necklace signs.
  • Discussion of microbiological confirmation difficulties and treatment protocols.

Main Results:

  • Hepatic melioidosis presents insidiously, often mistaken for pyogenic or amoebic liver abscesses.
  • Specific imaging signs (honeycomb, necklace) can aid in differentiation.
  • Microbiological misidentification can delay diagnosis, impacting treatment initiation.

Conclusions:

  • Hepatic melioidosis is an underdiagnosed but significant cause of liver abscess in endemic areas.
  • Enhanced clinician awareness and improved laboratory diagnostics are vital for accurate and prompt management.
  • Optimal treatment involves intensive intravenous antibiotics followed by an eradication phase, with drainage reserved for specific cases.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...